Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Weusten BLAM, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, Baldaque-Silva F, Barret M, Coron E, Fernández-Esparrach G, Fitzgerald RC, Jansen M, Jovani M, Marques-de-Sa I, Rattan A, Tan WK, Verheij EPD, Zellenrath PA, Triantafyllou K, Pouw RE.
Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440. Epub 2023 Oct 9.
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma.
McLean LS, Cavanagh K, Hicks RJ, Callahan J, Xie J, Cardin A, Lim AM, Rischin D.
Cancer Imaging. 2021 Oct 13;21(1):57. doi: 10.1186/s40644-021-00426-2.
PET/CT Specificities in (90)Y Imaging Post Radioembolization.
Stephan W, Michel H.
PET Clin. 2019 Oct;14(4):469-476. doi: 10.1016/j.cpet.2019.06.001. Epub 2019 Aug 6.
PET/CT for Target Delineation of Lung Cancer Before Radiation Therapy.
Manapov F, Eze C, Holzgreve A, Käsmann L, Nieto A, Taugner J, Unterrainer M.
Semin Nucl Med. 2022 Nov;52(6):673-680. doi: 10.1053/j.semnuclmed.2022.05.003. Epub 2022 Jun 30.
Lesion segmentation on (18)F-fluciclovine PET/CT images using deep learning.
Wang T, Lei Y, Schreibmann E, Roper J, Liu T, Schuster DM, Jani AB, Yang X.
Front Oncol. 2023 Dec 13;13:1274803. doi: 10.3389/fonc.2023.1274803. eCollection 2023.
A comparative study of [(68)Ga]Ga-FAPI-04 PET/MR and [(18)F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer.
Xi Y, Sun L, Che X, Huang X, Liu H, Wang Q, Meng H, Miao Y, Qu Q, Hai W, Li B, Feng W.
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2885-2898. doi: 10.1007/s00259-023-06235-y. Epub 2023 Apr 24.
Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 ((90)Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with (90)Y microspheres.
Knešaurek K, Tuli A, Kim E, Heiba S, Kostakoglu L.
EJNMMI Phys. 2018 Aug 30;5(1):23. doi: 10.1186/s40658-018-0222-y.
(18)F-choline PET/4D CT in hyperparathyroidism: correlation between biochemical data and study parameters.
Boccalatte LA, Gómez NL, Musumeci M, Galich AM, Collaud C, Figari MF.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):273-278. doi: 10.1016/j.remn.2020.03.017. Epub 2020 Jun 12.
Comprehensive literature review of oral and intravenous contrast-enhanced PET/CT: a step forward?
Metrard G, Cohen C, Bailly M.
Front Med (Lausanne). 2024 Mar 19;11:1373260. doi: 10.3389/fmed.2024.1373260. eCollection 2024.
PET/CT calibration for post-treatment standard body scan acquisition with yttrium-90 resin micro-SPHERES.
Uña-Gorospe JA, Baso-Pérez C, Cárdenas-Negro C, Merino-Gestoso JA, Portas-Ferradás BC, Allende-Riera A.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Nov-Dec;41(6):368-372. doi: 10.1016/j.remnie.2022.09.011. Epub 2022 Oct 3.
